Exacerbation of Chronic Obstructive Pulmonary Disease (Q38879639)

7 September 2017

1 reference

title

Exacerbation of Chronic Obstructive Pulmonary Disease (English)

1 reference

27352322

chronic obstructive pulmonary disease

7 September 2017

main subject

1 reference

Xianghui Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Qingling Li

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xincan Zhou

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 November 2015

1 reference

27352322

Cell Biochemistry and Biophysics

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

349-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Impact of COPD exacerbations on patient-centered outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Factors affecting survival of hospitalised patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Chronic obstructive pulmonary disease in non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Cigarette smoking and inflammation: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Review: Is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Indoor air pollution from biomass fuel smoke is a major health concern in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Woodsmoke health effects: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Oxidative stress, DNA damage, and inflammation induced by ambient air and wood smoke particulate matter in human A549 and THP-1 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Cellular and molecular mechanisms of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Phenotyping the heterogeneity of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

COPD in never smokers: results from the population-based burden of obstructive lung disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Virus-induced exacerbations in asthma and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Experimental rhinovirus infection in COPD: implications for antiviral therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

COPD exacerbations: causes, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

An explanation for the seasonality of acute upper respiratory tract viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Preventing influenza: an overview of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Prophylactic vaccinations in chronic obstructive pulmonary disease: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

COPD as a systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Metabolic Syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Impact of COPD exacerbations on osteoporosis assessed by chest CT scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-015-0605-9

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

12 December 2020

Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts.

1 reference

12 December 2020

Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease

1 reference

12 December 2020

Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease

1 reference

12 December 2020

Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.

1 reference

12 December 2020

Bacterial microbiome of lungs in COPD

1 reference

12 December 2020

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

1 reference

12 December 2020

Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease

1 reference

12 December 2020

10.1007/S12013-015-0605-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

27352322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27352322%20AND%20SRC:MED&resulttype=core&format=json